Nyheter - News

Filter by category

News Published: July 3, 2026

VERIGRAFT Q2 2026 – Advancing Clinical Execution
News Published: June 24, 2026

VERIGRAFT and BBG Advanced Therapies collaborate on P-TEV U.S. readiness
News Published: May 28, 2026

VERIGRAFT and TFS HealthScience partner on pivotal Phase II/III trial of personalized tissue-engineered vein for chronic venous insufficiency
News Published: May 13, 2026

VERIGRAFT Receives CTA Approval for Phase II/III Study of P-TEV
News Published: May 7, 2026

VERIGRAFT Q1 2026 – Continued Clinical Progress
News Published: February 12, 2026

VERIGRAFT announces a committed capital contribution of SEK 110 million to advance pivotal trial program in Europe and the US
News Published: May 27, 2025

Regulatory Greenlight Achieved in our Clinical Trial
News Published: April 30, 2025

VERIGRAFT winner of the Business Sweden’s Catalyst Program 2025
News Published: April 28, 2025

Q1 2025: Key milestones for VERIGRAFT in clinical progress, funding, and research
News Published: March 4, 2025

Testimonial by Fredrik Wessberg, CFO att CCRM Nordic